Suchergebnisse - "van Werkhoven, Erik"

PubPharm (153)

1

Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS

enthalten in: Blood advances | 2024

von de Jonge, A. | Duetz, C. | Bruins, W. | +17

2

High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer : the randomized phase III NeoTN trial

enthalten in: NPJ breast cancer | 2023

von Vliek, S. | Hilbers, F. | van Werkhoven, E. | +28

3

A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients

enthalten in: Blood cancer journal | 2023

von de Jonge, A. | van Werkhoven, E. | Dinmohamed, A. | +15

4

Immediate or delayed oncoplastic surgery after breast conserving surgery at the Netherlands Cancer Institute : a cohort study of 251 cases

enthalten in: Breast cancer research and treatment | 2023

von van Loevezijn, A. | Geluk, C. | van den Berg, M. | +4

5

Patterns of Recurrence and Survival After Pelvic Treatment for Locally Advanced Penile Cancer

enthalten in: European urology open science | 2023

von de Vries, H. | Ottenhof, S. | Rafael, T. | +9

6

Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer : a nationwide cohort analysis of pathologic response and 5-year survival

enthalten in: Breast (Edinburgh, Scotland) | 2022

von van der Voort, A. | Liefaard, M. | van Ramshorst, M. | +8

7

Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer : A post hoc analysis of the randomized phase III-trial AGITG-MAX

enthalten in: International journal of cancer | 2022

von van Dijk, E. | van Werkhoven, E. | Asher, R. | +8

8

Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer : the MARI-protocol

enthalten in: Breast cancer research and treatment | 2022

von van Loevezijn, A. | van der Noordaa, M. | Stokkel, M. | +8

9

FER regulates endosomal recycling and is a predictor for adjuvant taxane benefit in breast cancer

enthalten in: Cell reports | 2022

von Tavares, S. | Liv, N. | Pasolli, M. | +15

10

Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Hoes, L. | van Berge Henegouwen, J. | van der Wijngaart, H. | +27

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]